|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jung KW, Won YJ, Kong HJ, Oh CM, Shin A
and Lee JS: Survival of korean adult cancer patients by stage at
diagnosis, 2006–2010: National cancer registry study. Cancer Res
Treat. 45:162–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JY, Cho KB, Kim ES, Park KS, Lee YJ,
Lee YS, Jang BK, Chung WJ and Hwang JS: Risk factors for local
recurrence after en bloc endoscopic submucosal dissection for early
gastric cancer. World J Gastrointest Endosc. 8:330–337. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Y, Xu Q, Zuo Y, Liu L, Liu S, Chen L,
Wang K, Lei Y, Zhao X and Li Y: Isoprenaline/β2-AR activates
plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells
to promote tumor angiogenesis. BMC Cancer. 17:8752017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie M, Dart DA, Guo T, Xing XF, Cheng XJ,
Du H, Jiang WG, Wen XZ and Ji JF: MicroRNA-1 acts as a tumor
suppressor microRNA by inhibiting angiogenesis-related growth
factors in human gastric cancer. Gastric Cancer. 21:41–54. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
D'Angelo G, Di Rienzo T and Ojetti V:
Microarray analysis in gastric cancer: A review. World J
Gastroenterol. 20:11972–11976. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hitzemann R, Bottomly D, Darakjian P,
Walter N, Iancu O, Searles R, Wilmot B and McWeeney S: Genes,
behavior and next-generation RNA sequencing. Genes Brain Behav.
12:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moffett J, Kratz E, Florkiewicz R and
Stachowiak MK: Promoter regions involved in density-dependent
regulation of basic fibroblast growth factor gene expression in
human astrocytic cells. Proc Natl Acad Sci USA. 93:2470–2475. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coleman SJ, Chioni AM, Ghallab M, Anderson
RK, Lemoine NR, Kocher HM and Grose RP: Nuclear translocation of
FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic
cancer cell invasion. EMBO Mol Med. 6:467–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren T, Qing Y, Dai N, Li M, Qian C, Yang
Y, Cheng Y, Li Z, Zhang S, Zhong Z and Wang D:
Apurinic/apyrimidinic endonuclease 1 induced upregulation of
fibroblast growth factor 2 and its receptor 3 induces angiogenesis
in human osteosarcoma cells. Cancer Sci. 105:186–194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang
L, Lu K, Tao T, Zhang X and Huang Y: miR-195 inhibits EMT by
targeting FGF2 in prostate cancer cells. PLoS One. 10:e01440732015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SK and Hebrok M: Intercellular signals
regulating pancreas development and function. Genes Dev.
15:111–127. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Turner N and Grose R: Fibroblast growth
factor signalling: From development to cancer. Nat Rev Cancer.
10:116–129. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clarke WE, Berry M, Smith C, Kent A and
Logan A: Coordination of fibroblast growth factor receptor 1
(FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to
nuclei of reactive astrocytes around cerebral lesions in adult
rats. Mol Cell Neurosci. 17:17–30. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qian Z, Zhu G, Tang L, Wang M, Zhang L, Fu
J, Huang C, Fan S, Sun Y, Lv J, et al: Whole genome gene copy
number profiling of gastric cancer identifies PAK1 and KRAS gene
amplification as therapy targets. Genes Chromosomes Cancer.
53:883–894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lei Z, Tan IB, Das K, Deng N, Zouridis H,
Pattison S, Chua C, Feng Z, Guan YK, Ooi CH, et al: Identification
of molecular subtypes of gastric cancer with different responses to
PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology.
145:554–565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berlth F, Bollschweiler E, Drebber U,
Hoelscher AH and Moenig S: Pathohistological classification systems
in gastric cancer: Diagnostic relevance and prognostic value. World
J Gastroenterol. 20:5679–5684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Newman AM, Liu CL, Green MR, Gentles AJ,
Feng W, Xu Y, Hoang CD, Diehn M and Alizadeh AA: Robust enumeration
of cell subsets from tissue expression profiles. Nat Methods.
12:453–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamarudin AN, Cox T and Kolamunnage-Dona
R: Time-dependent ROC curve analysis in medical research: Current
methods and applications. BMC Med Res Methodol. 17:532017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho JY: Molecular diagnosis for
personalized target therapy in gastric cancer. J Gastric Cancer.
13:129–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guzy RD, Stoilov I, Elton TJ, Mecham RP
and Ornitz DM: Fibroblast growth factor 2 is required for
epithelial recovery, but not for pulmonary fibrosis, in response to
bleomycin. Am J Respir Cell Mol Biol. 52:116–128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferreras C, Rushton G, Cole CL, Babur M,
Telfer BA, van Kuppevelt TH, Gardiner JM, Williams KJ, Jayson GC
and Avizienyte E: Endothelial heparan sulfate 6-O-sulfation levels
regulate angiogenic responses of endothelial cells to fibroblast
growth factor 2 and vascular endothelial growth factor. J Biol
Chem. 287:36132–36146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maehara O, Suda G, Natsuizaka M, Ohnishi
S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, et al:
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports
maintenance of cancer stem-like cells in esophageal squamous cell
carcinoma. Carcinogenesis. 38:1073–1083. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lau MT, So WK and Leung PCK: Fibroblast
growth factor 2 induces E-cadherin down-regulation via
PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells. PLoS
One. 8:e590832013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Q, Ren X, Chen J, Li Y, Tang X, Wen X,
Yang X, Zhang J, Wang Y, Ma J and Liu N: miR-16 targets fibroblast
growth factor 2 to inhibit NPC cell proliferation and invasion via
PI3K/AKT and MAPK signaling pathways. Oncotarget. 7:3047–3058.
2016.PubMed/NCBI
|
|
30
|
Choi YY, Jang E, Seo WJ, Son T, Kim HI,
Kim H, Hyung WJ, Huh YM, Noh SH and Cheong JH: Modification of the
TNM staging system for stage II/III gastric cancer based on a
prognostic single patient classifier algorithm. J Gastric Cancer.
18:142–151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boeker M, França F, Bronsert P and Schulz
S: TNM-O: Ontology support for staging of malignant tumours. J
Biomed Semantics. 7:642016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hennequin A, Derangère V, Boidot R, Apetoh
L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L,
et al: Tumor infiltration by Tbet+ effector T cells and CD20+ B
cells is associated with survival in gastric cancer patients.
OncoImmunology. 5:e10545982015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS,
Lee BL and Kim WH: Prognostic implications of type and density of
tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer.
99:1704–1711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang WJ, Zhou ZH, Guo M, Yang LQ, Xu YY,
Pang TH, Gao ST, Xu XY, Sun Q, Feng M, et al: High infiltration of
polarized CD163+tumor-associated macrophages correlates with
aberrant expressions of CSCs markers, and predicts prognosis in
patients with recurrent gastric cancer. J Cancer. 8:363–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Galon J, Mlecnik B, Bindea G, Angell HK,
Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, et
al: Towards the introduction of the ‘Immunoscore’ in the
classification of malignant tumours. J Pathol. 232:199–209. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fridman WH, Pagès F, Sautès-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun HW, Tang QB, Cheng YJ and Zou SQ:
Effects of dendritic cells transfected with full-length wild-type
p53 and stimulated by gastric cancer lysates on immune response.
World J Gastroenterol. 10:2595–2597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He S, Wang L, Wu Y, Li D and Zhang Y: CCL3
and CCL20-recruited dendritic cells modified by melanoma antigen
gene-1 induce anti-tumor immunity against gastric cancer ex vivo
and in vivo. J Exp Clin Cancer Res. 29:372010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamaguchi T, Fushida S, Yamamoto Y,
Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I,
Munesue S, et al: Low-dose paclitaxel suppresses the induction of
M2 macrophages in gastric cancer. Oncol Rep. 37:3341–3350. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamaguchi T, Fushida S, Yamamoto Y,
Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I,
Munesue S, et al: Tumor-associated macrophages of the M2 phenotype
contribute to progression in gastric cancer with peritoneal
dissemination. Gastric Cancer. 19:1052–1065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yuan L, Xu B, Yuan P, Zhou J, Qin P, Han
L, Chen G, Wang Z, Run Z, Zhao P and Gao Q: Tumor-infiltrating
CD4+ T cells in patients with gastric cancer. Cancer
Cell Int. 17:1142017. View Article : Google Scholar : PubMed/NCBI
|
